您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (8): 61-65.doi: 10.6040/j.issn.1671-7554.0.2017.105

• 临床医学 • 上一篇    下一篇

ANGPTL5在人胃癌组织中的表达及临床意义

聂思月1,王震2,孙靖宇3,刘杰1,李娟1,魏小娟1,路春晓4,吕兴龑4,王淑云1,孙玉萍1   

  1. 1. 山东大学附属济南市中心医院肿瘤科, 山东 济南 250013;2. 济南市章丘区人民医院肿瘤化疗科, 山东 济南 250200;3. 山东大学生命科学院, 山东 济南 250100;4. 潍坊医学院, 山东 潍坊 261053
  • 收稿日期:2017-01-26 出版日期:2017-08-10 发布日期:2017-08-10
  • 通讯作者: 刘杰. E-mail:sdjnljjie@126.com E-mail:sdjnljjie@126.com

Expression and clinical significance of angiopoietin-like protein 5 in human gastric cancer tissues

NIE Siyue1, WANG Zhen2, SUN Jingyu3, LIU Jie1, LI Juan1, WEI Xiaojuan1, LU Chunxiao4, L(¨overU)Xingyan4, WANG Shuyun1, SUN Yuping1   

  1. 1. Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China;
    2. Department of Chemotherapy, Peoples Hospital of Zhangqiu, Jinan 250200, Shandong, China;
    3. School of Life Science, Shandong University, Jinan 250100, Shandong, China;
    4. Weifang Medical University, Weifang 261053, Shandong, China
  • Received:2017-01-26 Online:2017-08-10 Published:2017-08-10

摘要: 目的 探讨血管生成素样蛋白5(ANGPTL5)在人原发胃癌组织中的表达及与临床病理因素和预后的关系。 方法 收集73例胃癌组织及对应癌旁正常组织,通过免疫组织化学染色法检测ANGPTL5蛋白的表达。使用Pearson χ2检验和连续校正的χ2检验法分析癌组织与癌旁正常组织中ANGPTL5蛋白的表达差异及ANGPTL5蛋白与临床病理因素和预后的关系。 结果 ANGPTL5主要弥漫表达在胃癌细胞胞浆中,部分间质细胞中弱表达,癌旁正常组织ANGPTL5偶有表达。ANGPTL5在胃癌组织中的表达显著高于癌旁正常组织(χ2=38.939,P<0.001)。在胃癌组织中ANGPTL5的表达水平与原发肿瘤大小、浸润深度和TNM分期显著相关(P<0.05)。ANGPTL5高表达组总生存期明显低于低表达组(χ2=5.888,P=0.015)。 结论 ANGPTL5在胃癌组织中高表达,且与胃癌预后不良因素及较短生存期相关,提示ANGPTL5可能参与胃癌的进展,是潜在的胃癌预后不良因子和治疗靶点。

关键词: 血管生成素样蛋白5, 胃肿瘤, 总生存期, 免疫组织化学, 临床特征

Abstract: Objective To investigate the expression of angiopoietin-like protein 5(ANGPTL5)and its clinical significance in primary human gastric cancer(GC). Methods Using immunohistochemistry(IHC), the expression of ANGPTL5 protein in 73 human specimens was detected including GC tissues and adjacent normal tissues. Pearson Chi-square test and continuity correction for Pearson Chi-square test were used to analyze the difference of ANGPTL5 expression between cancer tissues and adjacent normal tissues and the association between clinical pathological parameters and ANGPTL5 expression in GC tissues. Results ANGPTL5 was mainly expressed in cytoplasm of GC cells, and faint staining was presented in parts of interstitial cells, but most of adjacent normal gastric cells had no or little ANGPTL5 expression. A significant overexpression of ANGPTL5 protein was presented in GC tissues compared with that in adjacent normal tissues(χ2=38.939,P<0.001). Moreover, ANGPTL5 expression was significantly associated with primary tumor size(χ2=5.006, P=0.025), depth of tumor infiltration(χ2=6.810, P=0.009)and TNM stages(χ2=4.867, P=0.027). Furthermore, the overall survival(OS)in ANGPTL5 positive group was lower than that in the negative group(χ2=5.888,P=0.015). Conclusion ANGPTL5 was highly expressed in GC tissues, which was 山 东 大 学 学 报 (医 学 版)55卷8期 -聂思月,等.ANGPTL5在人胃癌组织中的表达及临床意义 \=-associated with poorly prognostic factors and shorter OS, suggesting that ANGPTL5 may be involved in GC progression, and it might be a new potential poor prognostic indicator for GC treatment.

Key words: Clinical characteristics, Overall survival, Angiopoietin-like protein 5, Gastric neoplasms, Immunohistochemistry

中图分类号: 

  • R735.2
[1] Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index(2008-2030): a population-based study[J]. Lancet Oncol, 2012, 13(8):790-801.
[2] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[3] 徐飚,王建明. 胃癌流行病学研究[J]. 中华肿瘤防治杂志, 2006, 13(1):1-4.
[4] Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice[J]. Lancet Oncol, 2008, 9(3): 279-287.
[5] Yingsong L, Junko U, Shogo K, et al. Comparative epidemiology of gastric cancer between Japan and China[J]. World J of Gastroenterol, 2011, 17(39): 4421-4428.
[6] 陈万青,郑荣寿,曾红梅,等. 2011年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2016, 24(1): 1-10. CHEN Wanqing, ZHENG Rongshou, ZENG Hongmei, et al. Report of cancer incidence and mortality in China, 2011[J]. China Cancer, 2016, 24(1):1-10.
[7] 季加孚,季鑫. 胃癌新辅助化疗的现状与展望[J]. 中国肿瘤临床, 2012, 39(20): 1458-1461.
[8] Kim I, Moon SO, Koh KN, et al. Molecular cloning, expression, and characterization of angiopoietin-related protein[J]. J Bio Chem, 1999, 274(37): 26523-26528.
[9] Dhanabal M, Larochelle WJ, Jeffers M, et al. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties[J]. Cancer Res, 2002, 62(13): 3834-3841.
[10] Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism[J]. Trends Cardiovasc Med, 2008, 18(1): 6-14.
[11] Gusarova V, Alexa CA, Na E, et al. ANGPTL8(betatrophin)does not control pancreatic beta cell expansion[J]. Cell, 2014, 159(3): 691-696.
[12] Zeng L, Dai J, Ying K, et al. Identification of a novel human angiopoietin-like gene expressed mainly in heart[J]. J Hum Genet, 2003, 48(3): 159-162.
[13] Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans[J]. J Clin Invest, 2009, 119(1): 70-79.
[14] Zhang CC, Kaba M, Iizuka S, et al. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation[J]. Blood, 2008, 111(7): 3415-3423.
[15] Khoury M, Drake A, Chen Q, et al. Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential[J]. Stem Cells Dev, 2011, 20(20): 1371-1381.
[16] Lin MI, Price EN, Boatman S, et al. Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling[J]. Elife, 2015, 4(4). doi: 10.7554/eLife.05544.
[17] Zheng J, Umikawa M, Cui C, et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development[J]. Nature, 2012, 485(7400): 656-660.
[18] Wang L, Geng T, Guo X, et al. Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer[J]. Mol Med Rep, 2015, 11(4): 2789-2796.
[19] Gao L, Ge C, Fang T, et al. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2015, 30(2): 396-404.
[20] 张云,张文鹏,李健文,等. 血管生成素样蛋白2在结肠直肠癌的表达及其对结肠癌细胞迁移侵袭能力的影响[J]. 外科理论与实践, 2013, 18(4): 352-357. ZHANG Yun, ZHANG Wenpeng, LI Jianwen, et al. Expression of ANGPTL2 in colorectal cancer and its influence on invasion and migration of colon cancer cells[J]. J Surg Concepts Pract, 2013, 18(4): 352-357.
[21] 陈非,贾映东,郭黔,等. 结直肠癌患者血清ANGPTL2水平及其临床诊断价值研究[J]. 医学研究杂志, 2016, 45(7): 142-146. CHEN Fei, JIA Yingdong, GUO Qian, et al. Serum ANGPTL2 level in patients with colorectal cancer and its clinical diagnostic value[J]. J Med Res, 2016, 45(7): 142-146.
[22] Shimura T, Toiyama Y, Tanaka K, et al. Angiopoietin-like protein 2 as a predictor of early recurrence in patients after curative surgery for gastric cancer[J]. Anticancer Res, 2015, 35(9): 4633-4639.
[23] Toiyama Y, Tanaka K, Kitajima T, et al. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients[J]. Carcinogenesis, 2015, 36(12): 1474-1483.
[24] Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score(IRS)for immunohistochemical estrogen receptor detection(ER-ICA)in breast cancer tissue[J]. Der Pathologe, 1987, 8(8):138-140.
[25] Nakayama T, Hirakawa H, Shibata K, et al. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion[J]. Oncol Rep, 2010, 24(3): 599-606.
[1] 黄方 康瑞 吴春林. VEGFC、NF-κBp65及Survivin在鼻咽癌中的表达及临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 83-.
[2] 底学敏,牛书雷,赵静,杜随,于慧敏,张宏涛,王娟. CT引导下125I粒子植入治疗晚期胃癌淋巴结转移[J]. 山东大学学报(医学版), 2017, 55(9): 79-84.
[3] 王永强,张维全,孙启峰,董晓鹏,彭传亮,张媛,赵小刚. 细胞角蛋白14基因在非小细胞肺癌中的表达与意义[J]. 山东大学学报(医学版), 2017, 55(3): 83-87.
[4] 张希英,翟春颜,李劲松,韩博. 中国尤文肉瘤患者EZH2蛋白表达与临床病理学参数及预后的关系[J]. 山东大学学报(医学版), 2017, 55(2): 84-91.
[5] 刘惠苓,王兴文,冯少滨,冯虹,韩俊庆. B类I型清道夫受体的高表达与结肠癌患者预后的相关性[J]. 山东大学学报(医学版), 2017, 55(10): 84-89.
[6] 王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报(医学版), 2016, 54(8): 72-77.
[7] 王光杰,俎树禄,张秀琳,徐祗顺,周春文,刘玉强,王绍勇. Von-Hippel-Lindau病并发肾癌2例[J]. 山东大学学报(医学版), 2016, 54(2): 86-89.
[8] 王成, 荣艳华, 沈余明,张国安. 正常皮肤与增生性瘢痕中Ⅰ型和Ⅲ型胶原的含量与比例[J]. 山东大学学报(医学版), 2016, 54(11): 64-67.
[9] 谷旭, 王夏青, 任万华, 秦成勇, 韩国庆. NPRL2、Survivin在肝细胞肝癌中的表达及其临床意义[J]. 山东大学学报(医学版), 2015, 53(6): 68-72.
[10] 姚冬雪, 赵琪, 秦成勇. miRNA-206在胃间质瘤组织中的表达及其临床意义[J]. 山东大学学报(医学版), 2015, 53(12): 67-70.
[11] 丁娟, 郑桂喜, 杜鲁涛, 尹作花, 张建, 王传新. 外周血sHLA-G与PGR、GPR联合检测在胃癌诊断中的效能评估[J]. 山东大学学报(医学版), 2015, 53(11): 59-63.
[12] 张明超, 聂云天. CDK8与E-cad在子宫内膜癌的发生、发展中的表达意义[J]. 山东大学学报(医学版), 2014, 52(S1): 12-13.
[13] 连海峰, 李明, 刘成霞, 贾兴芳, 李丹. NRP2在胃癌中的表达及其临床意义[J]. 山东大学学报(医学版), 2014, 52(7): 56-59.
[14] 孙莹, 于晶, 魏军民, 樊聪, 王秀问, 高鹏, 江立玉, 马婷婷. 35岁以下女性乳腺癌患者的临床病理特征[J]. 山东大学学报(医学版), 2014, 52(7): 71-74.
[15] 张诤, 申洪昌, 付国斌, 张建超, 王潍博. GRK6在胃癌中的表达及其预后价值[J]. 山东大学学报(医学版), 2014, 52(7): 50-55.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!